Format
Sort by
Items per page

Send to

Choose Destination

Best matches for mammography AND woman:

Study on knowledge, experiences and barriers to mammography among working women from Delhi. Khokhar A et al. Indian J Cancer. (2015)

Recall mammography and psychological distress. Schou Bredal I et al. Eur J Cancer. (2013)

Validating self-reported mammography use in vulnerable communities: findings and recommendations. Allgood KL et al. Cancer Epidemiol Biomarkers Prev. (2014)

Search results

Items: 1 to 20 of 12978

1.

Determinants of breast size in Asian women.

Lim LY, Ho PJ, Liu J, Chay WY, Tan MH, Hartman M, Li J.

Sci Rep. 2018 Jan 19;8(1):1201. doi: 10.1038/s41598-018-19437-4.

2.

Is DCIS Overrated?

Feinberg J, Wetstone R, Greenstein D, Borgen P.

Cancer Treat Res. 2018;173:53-72. doi: 10.1007/978-3-319-70197-4_5.

PMID:
29349758
3.

Breast Cancer Screening: The Debate that Never Ends.

Friedewald SM.

Cancer Treat Res. 2018;173:31-38. doi: 10.1007/978-3-319-70197-4_3.

PMID:
29349756
4.

Dense Breast Notification Laws: Impact on Downstream Imaging After Screening Mammography.

Horný M, Cohen AB, Duszak R Jr., Christiansen CL, Shwartz M, Burgess JF Jr..

Med Care Res Rev. 2018 Jan 1:1077558717751941. doi: 10.1177/1077558717751941. [Epub ahead of print]

PMID:
29347864
5.

High Participation Rate in Mammography Screening: Experience from Croatia.

Puharić Z, Žulec M, Ceronja I, Parun AŠ.

Cent Eur J Public Health. 2017 Dec;25(4):303-306. doi: 10.21101/cejph.a4684.

PMID:
29346854
6.

Evaluation of nipple aspirate fluid as a diagnostic tool for early detection of breast cancer.

Shaheed SU, Tait C, Kyriacou K, Linforth R, Salhab M, Sutton C.

Clin Proteomics. 2018 Jan 11;15:3. doi: 10.1186/s12014-017-9179-4. eCollection 2018. Review.

7.

Elimination of Cost Sharing for Screening Mammography in Medicare Advantage Plans.

Trivedi AN, Leyva B, Lee Y, Panagiotou OA, Dahabreh IJ.

N Engl J Med. 2018 Jan 18;378(3):262-269. doi: 10.1056/NEJMsa1706808.

PMID:
29342379
8.

Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk.

Miles R, Wan F, Onega TL, Lenderink-Carpenter A, O'Meara ES, Zhu W, Henderson LM, Haas JS, Hill DA, Tosteson ANA, Wernli KJ, Alford-Teaster J, Lee JM, Lehman CD, Lee CI.

J Womens Health (Larchmt). 2018 Jan 17. doi: 10.1089/jwh.2017.6623. [Epub ahead of print]

PMID:
29341851
9.

Family History and Risk of Second Primary Breast Cancer after In Situ Breast Carcinoma.

Baglia ML, Tang MC, Malone KE, Porter P, Li CI.

Cancer Epidemiol Biomarkers Prev. 2018 Jan 16. pii: cebp.0837.2017. doi: 10.1158/1055-9965.EPI-17-0837. [Epub ahead of print]

PMID:
29339357
10.

Primary Care Provider Experience with Breast Density Legislation in Massachusetts.

Gunn CM, Kressin NR, Cooper K, Marturano C, Freund KM, Battaglia TA.

J Womens Health (Larchmt). 2018 Jan 17. doi: 10.1089/jwh.2017.6539. [Epub ahead of print]

PMID:
29338539
11.

The role of screening mammography in the era of modern breast cancer treatment.

Miller AB.

Climacteric. 2018 Jan 17:1-5. doi: 10.1080/13697137.2017.1392503. [Epub ahead of print]

PMID:
29338480
12.

Retroareolar masses and intraductal abnormalities detected on screening ultrasound: can biopsy be avoided?

Guo Y, Raghu M, Durand M, Hooley R.

Br J Radiol. 2018 Jan 17:20170816. doi: 10.1259/bjr.20170816. [Epub ahead of print]

PMID:
29338316
13.

The impact of compression force and pressure at prevalent screening on subsequent re-attendance in a national screening program.

Moshina N, Sebuødegård S, Holen ÅS, Waade GG, Tsuruda K, Hofvind S.

Prev Med. 2018 Jan 11;108:129-136. doi: 10.1016/j.ypmed.2018.01.008. [Epub ahead of print]

PMID:
29337068
14.

Case Report: Synchronous primary malignancy including the breast and endometrium.

Bani-Mostafavi ES, Tayebi S, Tayebi M, Montazer F.

Version 2. F1000Res. 2017 Aug 17 [revised 2017 Jan 1];6:1502. doi: 10.12688/f1000research.11971.2. eCollection 2017.

15.

Women's satisfaction with mammography and predictors of participation in an organized breast cancer screening program: Perspectives of a Local Health Unit in Rome.

Unim B, Boggi R, Napoli M, Fulgenzi R, Landi A, La Torre G.

Public Health. 2018 Jan 11;155:91-94. doi: 10.1016/j.puhe.2017.11.025. [Epub ahead of print]

PMID:
29331770
16.

Breast cancer screening: Where have we been and where are we going? A personal perspective based on history, data and experience.

Kopans DB.

Clin Imaging. 2017 Dec 27;50:91-95. doi: 10.1016/j.clinimag.2017.12.013. [Epub ahead of print] Review.

PMID:
29331672
17.

Systematic Review of Mammography Screening Educational Interventions for Hispanic Women in the United States.

Luque JS, Logan A, Soulen G, Armeson KE, Garrett DM, Davila CB, Ford ME.

J Cancer Educ. 2018 Jan 12. doi: 10.1007/s13187-018-1321-0. [Epub ahead of print] Review.

PMID:
29330754
18.

Interval breast cancers in the 'screening with tomosynthesis or standard mammography' (STORM) population-based trial.

Houssami N, Bernardi D, Caumo F, Brunelli S, Fantò C, Valentini M, Romanucci G, Gentilini MA, Zorzi M, Macaskill P.

Breast. 2018 Jan 9;38:150-153. doi: 10.1016/j.breast.2018.01.002. [Epub ahead of print]

PMID:
29328943
19.

Social determinants of health related to adhesion to mammography screening.

Moreira CB, Fernandes AFC, Castro RCMB, Oliveira RDP, Pinheiro AKB.

Rev Bras Enferm. 2018 Jan-Feb;71(1):97-103. doi: 10.1590/0034-7167-2016-0623. English, Portuguese.

20.

Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review.

Petelin L, Trainer AH, Mitchell G, Liew D, James PA.

Genet Med. 2018 Jan 11. doi: 10.1038/gim.2017.255. [Epub ahead of print]

PMID:
29323669

Supplemental Content

Loading ...
Support Center